NCT Number: NCT00369005
Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants
The purpose of this study was to determine whether restrictive guidelines for red blood cell (RBC) transfusions for preterm infants can reduce the number of transfusions without adverse consequences.
Looking for future studies?
Notify MeKey information
Conditions
Age range
0 year–2 week
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
Design, Setting, and Patients. We enrolled 100 hospitalized preterm infants with birth weights 500 to 1300 g into a randomized clinical trial comparing two levels of hematocrit threshold for RBC transfusion.
Intervention. The infants were randomly assigned to either the liberal or the restrictive transfusion group. For each group, transfusions were given only when the hematocrit fell below the assigned value. In each group, the transfusion thresholds decreased with improving clinical status.
Main Outcome Measures. We recorded the number of transfusions, the number of donor exposures, and various clinical and physiological outcomes.
Results. Infants in the liberally transfused group received more RBC transfusions, mean 5.2 (SD 4.5) vs 3.3 (SD 2.9) in the restrictive transfusion group (P=0.025). However, the number of donors to whom the infants were exposed was not significantly different, mean 2.8 (SD 2.5) vs 2.2 (SD 2.0). There was no difference between the groups in the percentage of infants who avoided transfusions altogether, 12% in the liberal transfusion group vs 10% in the restrictive group. Infants in the restrictive group were more likely to have intraparenchymal brain hemorrhage or periventricular leukomalacia (P=0.012), and they had more frequent episodes of apnea (P=0.004), including both mild and severe episodes.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Preterm infant
- Birth weight 500-1300 grams
Exclusion criteria
- Alloimmune hemolytic disease
- Congenital heart disease
- Other major birth defect requiring surgery
- Chromosomal abnormality
- Thought to be facing imminent death
- Parental philosophical or religious objections to transfusion
- More than 2 transfusions before enrollment
- Participation in other research study with potential impact on this study
Treatment and study plan
Primary outcomes
-
number of red blood cell transfusions
-
number of transfusion donors
Secondary outcomes
-
survival to discharge
-
patent ductus arteriosus
-
germinal matrix or intraventricular hemorrhage
-
periventricular leukomalacia
-
retinopathy of prematurity
-
bronchopulmonary dysplasia
-
duration of assisted ventilation
-
duration of supplemental oxygen therapy
-
number and frequency of all apnea episodes
-
number and frequency of apnea episodes requiring tactile stimulation
-
number and frequency of apnea episodes requiring assisted ventilation
-
number and frequency of apnea episodes during the 24 hours before and after each transfusion
-
time to regain birth weight
-
time to double birth weight
-
length of hospitalization
-
hemoglobin
-
hematocrit
-
reticulocyte count
-
oxygen saturation (pulse oximetry)
-
cardiac output (echocardiography)
-
blood lactic acid
-
plasma erythropoietin
-
serum ferritin
Sponsors and collaborators
Lead sponsor
University of Iowa
Other
Collaborators
- National Institutes of Health (NIH)
Registry information
Official study title
Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm Infants
Important dates
- Study start
- 1992
- Study completion
- 1999
- First posted
- Aug 29, 2006
- Registry last updated
- Aug 29, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
NCT01203501
Brain Damage, Chronic, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsAntenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage
NCT00009620
Brain Diseases, Brain Injuries
Palo Alto, California, United States
View Trial DetailsVitamin E for Extremely Preterm Infants
NCT01193270
Brain Diseases, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsA Study on the Effects of Feeding and Feeding Methods on Breathing Pattern in Very Low Birth Weight Preterm Infants
NCT00607555
Apnea, Female Urogenital Diseases and Pregnancy Complications
Toronto, Ontario, Canada
View Trial Details